Article
Cuproptosis-related genes predict prognosis and trastuzumab therapeutic response in HER2-positive breast cancer
5 Feb 2024
Abstract excerpt
Breast cancer is the most common diagnosed cancer, the HER2-positive subtype account for 15% of all breast cancer. HER2-targeted therapy is the mainstay treatment for HER2-positive breast cancer. Cuproptosis is a novel form of programmed cell death, and is caused by mitochondrial lipoylation and destabilization of iron-sulfur proteins triggered by copper, which was considered as a key player in various biological...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
